Safety, pharmacokinetics, and antiretroviral activity of islatravir (ISL, MK-8591), a novel nucleoside reverse transcriptase translocation inhibitor, following single-dose administration to treatment-naive adults infected with HIV-1: an open-label, phase 1b, consecutive-panel trial
Titel:
Safety, pharmacokinetics, and antiretroviral activity of islatravir (ISL, MK-8591), a novel nucleoside reverse transcriptase translocation inhibitor, following single-dose administration to treatment-naive adults infected with HIV-1: an open-label, phase 1b, consecutive-panel trial
Auteur:
Schürmann, Dirk Rudd, Deanne Jackson Zhang, Saijuan De Lepeleire, Inge Robberechts, Martine Friedman, Evan Keicher, Christian Hüser, Andreas Hofmann, Jörg Grobler, Jay A Stoch, S Aubrey Iwamoto, Marian Matthews, Randolph P